Lauren M. Sabella, Chief Commercial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,113 shares at $42.04 ($299K) on 2015-12-22, disclosed to the SEC on 2015-12-23.
Scheduled sale ($299k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-21 | $210K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |